MAI Capital Management’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.46M | Sell |
36,085
-1,388
| -4% | -$56.3K | 0.01% | 548 |
|
|
2025
Q1 | $1.64M | Sell |
37,473
-215
| -0.6% | -$9.42K | 0.01% | 508 |
|
|
2024
Q4 | $1.62M | Sell |
37,688
-389
| -1% | -$16.7K | 0.01% | 505 |
|
|
2024
Q3 | $1.69M | Sell |
38,077
-720
| -2% | -$31.9K | 0.02% | 417 |
|
|
2024
Q2 | $1.54M | Sell |
38,797
-1,171
| -3% | -$46.6K | 0.02% | 458 |
|
|
2024
Q1 | $1.72M | Buy |
39,968
+13
| +0% | +$561 | 0.02% | 426 |
|
|
2023
Q4 | $1.66M | Sell |
39,955
-4,238
| -10% | -$176K | 0.02% | 350 |
|
|
2023
Q3 | $1.76M | Sell |
44,193
-4,239
| -9% | -$169K | 0.03% | 323 |
|
|
2023
Q2 | $1.99M | Sell |
48,432
-537
| -1% | -$22K | 0.03% | 299 |
|
|
2023
Q1 | $2.01M | Sell |
48,969
-772
| -2% | -$31.7K | 0.03% | 284 |
|
|
2022
Q4 | $2.04M | Sell |
49,741
-390
| -0.8% | -$16K | 0.03% | 283 |
|
|
2022
Q3 | $2.01M | Sell |
50,131
-1,200
| -2% | -$48.2K | 0.04% | 250 |
|
|
2022
Q2 | $2.16M | Sell |
51,331
-956
| -2% | -$40.2K | 0.04% | 235 |
|
|
2022
Q1 | $2.37M | Sell |
52,287
-332
| -0.6% | -$15K | 0.04% | 237 |
|
|
2021
Q4 | $2.43M | Buy |
+52,619
| New | +$2.43M | 0.04% | 240 |
|